Breast care for transgender and gender-diverse persons requires consideration of unique histopathologic and anatomic changes induced by gender-affirming hormonal therapy and surgery, inclusive clinical environments, and tailored screening and risk assessment approaches.
Key Findings
Background
Transgender and gender-diverse persons represent a small but growing population in the United States facing challenges in accessing inclusive, equitable, and evidence-based healthcare.
TGD persons seek gender-affirming care including gender-affirming hormonal therapy (GAHT) and gender-affirming surgery (GAS)
The literature specifically addressing breast care needs in TGD patients is described as 'scarce but growing'
Accessing inclusive, equitable, and evidence-based healthcare 'remains a challenge for this patient population'
Background
Both GAHT and GAS induce clinically important histopathologic and anatomic changes in breast tissue of TGD persons.
These changes are described as 'clinically important histopathologic and anatomic changes in breast tissue'
The influence of GAHT and GAS on breast tissue is identified as a key topic requiring clinical review
These changes have made breast care 'an increasingly recognized topic of importance in gender-affirming care'
Background
Establishing trusting patient-provider relationships is identified as a foundational component of breast care for TGD patients.
The paper reviews how to establish trusting patient-provider relationships as a distinct clinical consideration
Gender inclusivity in breast clinics and imaging centers is identified as a separate but related concern
These relational and structural factors are listed alongside clinical considerations such as screening and risk assessment
Background
Breast cancer screening recommendations and barriers represent a distinct area of concern specific to TGD persons.
The paper reviews 'breast cancer screening recommendations and barriers' as a dedicated topic for TGD patients
Breast cancer risk and treatment considerations in TGD persons are reviewed separately from screening
The unique healthcare needs of TGD patients necessitate tailored approaches to screening that differ from cisgender patient protocols
Background
Gender inclusivity in breast clinics and imaging centers is identified as a necessary structural consideration for TGD patient care.
Gender inclusivity in breast clinics and imaging centers is explicitly listed as a topic of review
This is framed as part of providing equitable care to TGD persons
The clinical environment is treated as a distinct factor alongside medical and surgical considerations
Carroll E, Rogers C, Summerside M, Cortina C. (2024). Breast care considerations for transgender and gender-diverse patients.. Women's health (London, England). https://doi.org/10.1177/17455057241289706